27. cephalalgia2007updated pain model

Upload: denis-harli-siregar

Post on 20-Feb-2018

213 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    1/11

    REVIEW

    Myofascial trigger points and sensitization: an updated painmodel for tension-type headache

    C Fernndez-de-las-Peas1,2, ML Cuadrado2,3, L Arendt-Nielsen4, DG Simons5 & JA Pareja2,31Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation and 2Aesthesiology Laboratory, Universidad

    Rey Juan Carlos, 3Departments of Neurology, Fundacin Hospital Alcorcn and Universidad Rey Juan Carlos, Alcorcn, Madrid, Spain,4Centre for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Aalborg University, Aalborg, Denmark and5Rehabilitation Medicine at Emory University, Atlanta, GA, USA

    Fernndez-de-las-Peas C, Cuadrado ML, Arendt-Nielsen L, Simons DG &Pareja JA. Myofascial trigger points and sensitization: an updated pain model fortension-type headache. Cephalalgia 2007; 27:383393. London. ISSN 0333-1024

    Present pain models for tension-type headache suggest that nociceptive inputs

    from peripheral tender muscles can lead to central sensitization and chronictension-type headache (CTTH) conditions. Such models support that possibleperipheral mechanisms leading to pericranial tenderness include activation orsensitization of nociceptive nerve endings by liberation of chemical mediators(bradikinin, serotonin, substance P). However, a study has found that non-specific tender points in CTTH subjects were not responsible for liberation ofalgogenic substances in the periphery. Assuming that liberation of algogenicsubstances is important, the question arising is: if tender muscle points are notthe primary sites of on-going neurogenic inflammation, which structure can beresponsible for liberation of chemical mediators in the periphery? A recent studyhas found higher levels of algogenic substances, and lower pH levels, in activemyofascial trigger point (TrPs) compared with control tender points. Clinicalstudies have demonstrated that referred pain elicited by head and neck muscles

    contribute to head pain patterns in CTTH. Based on available data, an updatedpain model for CTTH is proposed in which headache can at least partly beexplained by referred pain from TrPs in the posterior cervical, head and shouldermuscles. In this updated pain model, TrPs would be the primary hyperalgesiczones responsible for the development of central sensitization in CTTH. Algo-genic substances, central sensitization, myofascial trigger points, peripheral nociception,tension-type headache

    Csar Fernndez de las Peas, Facultad de Ciencias de la Salud, Universidad ReyJuan Carlos, Avenida de Atenas s/n, 28922 Alcorcn, Madrid, Spain. Tel. +34 91488 8884, fax +34 9 1488 8957, e-mail [email protected], [email protected]

    Introduction

    Headache is one of the most common problemsseen in medical practice. Among the many types ofheadache disorders, tension-type headache (TTH) isone of the most prevalent in adults. Population-based studies suggest 1-year prevalence rates of38.3% for episodic TTH and 2.2% for chronic TTH

    (1). In addition, the prevalence of TTH hasincreased in recent years (2).

    Despite some advances, the pathogenesis of TTHis not clearly understood. It has been demonstratedthat the most prominent clinical finding in bothadults and children suffering from TTH is anincreased tenderness to palpation of pericranialtissues (37). The increased tenderness seems to be

    doi:10.1111/j.1468-2982.2007.01295.x

    383 Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

    mailto:[email protected]:[email protected]:[email protected]:[email protected]
  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    2/11

    uniformly increased throughout the pericranialregion and both the muscles and tendon insertionshave been found to be excessively tender (6, 7). Inaddition, it has also been reported that pressurepain threshold (PPT) levels are lower in patientswith chronic tension-type headache (CTTH) com-pared with control healthy subjects (810).

    It has been postulated that increased pericranialtenderness and decreased PPT levels in CTTHsubjects may be due to an increased sensitivity(hyperexcitability) in the central nervous systemor in the periphery. However, the demonstrationof a relation between pericranial tenderness andcentral sensitization does not reveal the causeeffect relationship between these factors. Bendtsenet al. (11) established a pain model in which themain problem in CTTH is the sensitization ofcentral pathways due to prolonged nociceptiveinputs, possibly provoked by the liberation of

    algogenic substances at the periphery, from peri-cranial myofascial tender tissues. The presence ofprolonged peripheral inputs can be a mechanismof major importance for the conversion of episodicinto chronic TTH (11). The proposed modelexplains the sensitization at the level of the spinaldorsal horn/trigeminal nucleus, the slightlyincreased supraspinal hypersensitivity, the slightlyincreased muscle activity, the increased musclehardness, the chronic pain and the absence ofobjective signs of peripheral pathology in patientswith CTTH with increased pericranial tenderness.

    However, the model does not account for themechanisms that initiate the central sensitization,i.e. the structures responsible for the nociceptiveinput from the periphery (11).

    The aims of the present paper were: (i) to reviewthe fundamental neurophysiology of central sensi-tization in CTTH; and (ii) to update the pain modelfor CTTH based on recent histochemical andclinical studies on referred muscle pain in TTHpatients.

    Central sensitization in CTTH

    Sensitization of peripheral muscle nociceptors byliberation of algogenic substances

    Spinal dorsal horn neurons that receive inputsfrom myofascial tissues can be classified as high-threshold mechano-sensitive (HTM) neurons, whichrequire noxious intensities of stimulation for acti-vation, or as low-threshold mechano-sensitive(LTM) neurons, which are activated by innocuous

    stimuli (12). It has been demonstrated that HTMdorsal horn neurons have a positively acceleratingstimulusresponse function, whereas LTM neuronshave a linear stimulusresponse function (13). Thisfinding suggests that the linear stimulusresponsefunction in human muscles may be caused by activ-ity in LTM afferents, although at first this seemsunlikely. Furthermore, several studies have demon-strated that prolonged noxious input from theperiphery is capable of sensitizing spinal dorsalhorn neurons, showing that LTM afferents canmediate pain (12, 1416).

    It is known that chemical mediators may sen-sitize the nociceptive nerve endings. Particularlyeffective stimulants for skeletal muscle nociceptorsare endogenous substances such as bradykinin orserotonin (12). Several studies have found thatsensitization of nociceptive nerve endings isgreater with the combination of both substances

    rather than with each substance alone (17, 18).Therefore, muscle pain is produced mainly bynoxious stimuli that lead to increased synthesisand release of endogenous algogenic substancessuch as serotonin, bradykinin, histamine or pros-taglandins. Such stimuli may cause the antidromicrelease of neuropeptides from the nerve endingsof C fibres which contain neuropeptides such ascalcitonin gene-related peptide, substance P orneurokinin A (19, 20). The liberation of algogenicsubstances would lower tissue pH and then acti-vate the arachidonic acid cascade that produces a

    number of unsaturated lipid products. Sensitiza-tion of nociceptors would cause spontaneous neu-ronal discharge, a lowered threshold to stimulithat normally provoke pain and an increasedfiring to stimuli that are not ordinarily perceivedas painful. Previous studies have confirmed thepresence of sensitization of peripheral musclenociceptors in both chronic (11) and episodic TTH(21, 22). Finally, other inflammatory chemicalsbelieved to be involved include bradykinin fromplasma, serotonin (5HT) from platelets andglutamate, which are known to affect the mem-branes of polymodal nociceptors to produce sen-

    sitization (23).In addition, activation of silent peripheral noci-

    ceptors might result in a qualitatively changedstimulusresponse function, explaining the abnor-mal stimulusresponse function seen in patientswith chronic myofascial pain (24). Further, it hasbeen recently found that the displacement of thestimulusresponse function is closely associatedwith frequency of headache in CTTH sufferers(25).

    384 C Fernndez-de-las-Peas et al.

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    3/11

    Sensitization of second-order neurons inthe dorsal horn and in the trigeminalnucleus caudalis

    Central sensitization can be generated by prolongednociceptive inputs from the periphery (26). Thismechanism is particularly important in patientswith chronic myofascial pain, since inputs frommuscle nociceptors are more effective in inducingprolonged changes in the behaviour of dorsal hornneurons than inputs from cutaneous nocicep-tors (27).

    Increased excitability of the dorsal horn neuronswould alter pain perception significantly. In thissensitized state, previously ineffective low-threshold Abfibre inputs to nociceptive dorsal hornneurons may become effective (28. 29). In such away, pain could be generated by low-threshold Abfibres, which clinically will manifest as allodynia.

    It has been suggested that the major cause ofincreased pain sensitivity in chronic pain is anabnormal response to inputs from low-threshold Abfibres (30). In addition, the response to activation ofhigh-threshold afferents would be exaggerated,which clinically will manifest itself as hyperalgesia.Decreased PPT levels, i.e. local hyperalgesia, hasbeen found in both cephalic (9, 10) and extracepha-lic (8, 31) sites in CTTH, and other chronic muscu-loskeletal conditions such as whiplash (32).

    Further, in the sensitized state, the afferent Abfibres, which normally inhibit Ad and C fibres by

    presynaptic mechanisms in the dorsal horn, will, onthe contrary, stimulate the nociceptive second-orderneurons. Therefore, the effect of Ad and C fibrestimulation of the nociceptive dorsal horn neuronswill be promoted and the receptive fields of thedorsal horn neurons will be expanded (33). Thenociceptive input to supraspinal structures willbe considerably increased and, if more spatialinput exists, may result in increased excitability ofsupraspinal neurons (34) and decreased inhibitionor increased facilitation of nociceptive transmissionin the spinal dorsal horn (35), which will manifestclinically as generalized pain hypersensitivity. Gen-

    eralized hyperalgesia has been recently demon-strated in CTTH patients (36), and other chronicmusculoskeletal conditions, i.e. osteoarthritis (37)and fibromyalgia (38).

    Which peripheral structure is responsible for theliberation of algogenic substances?

    Actual pain models for TTH establish that pro-longed nociceptive inputs from myofascial tender

    tissues, i.e. peripheral sensitization of musclenociceptors provoked by the liberation of algogenicsubstances, could lead to central sensitization inCTTH (11). The question arising is: which structuresand mechanisms are responsible for initiating theliberation of algogenic substances in the periphery?

    Bendtsen et al. have suggested that pericranialtender points could lead to central sensitizationin CTTH (11). However, Ashina et al. found nodifference in change in interstitial concentration ofadenosine 5-triphospate (ATP), glutamate, bradiki-nin, prostaglandin E2, glucose, pyruvate and ureafrom baseline to exercise and post-exercise periodsbetween non-specific tender points of CTTH sub-jects and controls (39). Authors of that study con-cluded that tender points in CTTH subjects are notresponsible for liberation of algogenic substances inthe periphery (39). On the other hand, significantlyhigher levels of algogenic substances, i.e. bradyki-

    nin, calcitonin gene-related peptide, substance P,tumour necrosis factor-a, interleukin-1b, serotoninand norepinephrine, and lower pH levels, havebeen found in active but not in latent myofascialtrigger points (TrPs) (40). Since tender points(increased tenderness, local but not referred pain)and myofascial TrPs (hypersensitive spot, taut bandin a skeletal muscle, both local and referred painpattern) are different disorders, we can update thepain model for TTH based on peripheral sensitiza-tion of muscle nociceptors provoked by myofascialTrPs.

    In conclusion, intense afferent nociceptive inputfrom peripheral muscle sensitization may alter thedorsal horn circuitry by unmasking, or activating,previously ineffective synapses to form novel syn-aptic contacts between low-threshold afferentsand high-threshold mechanosensitive dorsal hornneurons (41). Therefore, in these patients the pro-longed nociceptive input from muscle TrPs maylead to sensitization of nociceptive second-orderneurons at the level of the spinal dorsal/trigeminalnucleus.

    Muscle referred pain and myofascialtrigger points

    Convergence of nociceptive inputs on thetrigeminal nucleus caudalis explaining musclereferred pain to the head

    Small diameter group III and IV fibres from neckand shoulder muscles terminate mainly on neuronslocated in the superficial and intermediate dorsalhorn (laminae I and V) of the spinal cord (42, 43).

    Myofascial trigger points and sensitization 385

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    4/11

    Myofascial afferents from several different areasconverge onto the same second-order nociceptiverelay neurons in the spinal cord and the trigeminalnucleus caudalis. Animal (44) and human (45, 46)studies have clearly shown the convergence of cer-vical and trigeminal afferents in the trigeminalnerve nucleus caudalis, constituting the anatomicalbasis for the referred head pain from neck andshoulder muscles. Since nociceptive somaticafferents from muscles of the upper cervical roots,particularly C1 to C3, and the trigeminal nerve,particularly V1 (oftalmic) and V3 (mandible)nerves, converge on the same relay neurons, it isassumed that the message to supraspinal structurescan be misinterpreted and localized as pain in otherstructures distant from the site of painful stimulus(muscle referred pain).

    In addition, dorsal horn neurons that receiveafferents from muscles frequently receive input

    from other structures (47, 48). This extensive con-vergent input to dorsal horn neurons may accountfor the often diffuse and poorly localized natureof deep pain sensation in humans, particularlywhen pain is intense. In addition, animal studieshave demonstrated spinal level spread of the painmessage from one dorsal horn cell to another that isinitiated by strong input from muscle nociceptors(29, 49) and can be interpreted as a likely contrib-uting cause of muscle referred pain (50).

    Different experimental pain models have beenproposed in order to elicit referred pain from peri-

    cranial muscles. Hypertonic saline injections inducefiring in a large proportion of Ad and C fibres andcause deep, aching, referred pain in humans, simi-larly to clinical muscle pain (51). Schmidt-Hansenet al. have recently demonstrated that referred painelicited by the infusion of hypertonic saline into theanterior or posterior temporalis muscles is per-ceived as head pain (trigeminal or cervical der-matomes) in healthy subjects (52). Further, Ge et al.have demonstrated that injection of hypertonicsaline into the upper trapezius muscle elicited areferred pain to the neck and to the head in asymp-tomatic subjects (53, 54).

    Clinical and physiological presentation ofmyofascial trigger points

    Simons et al. define a TrP as a hyperirritable spotassociated within a taut band of a skeletal musclethat is painful on compression, and usually res-ponds with a referred pain pattern distant from thespot (a TrP) (55). From a clinical viewpoint, activeTrPs cause pain symptoms, and their local and

    referred pain is responsible for patients complaints.In patients, the referred pain elicited by active TrPreproduces at least part of their clinical painpattern. Latent TrPs also evoke referred pain withmechanical stimulation or muscle contraction, butthis pain is not a usual or familiar pain for thepatient. Both active and latent TrPs can provokemotor dysfunctions, e.g. muscle weakness orimbalance, altered motor recruitment (56), in eitherthe affected muscle or in functionally relatedmuscles (55).

    The formation of TrPs may result from a varietyof factors (e.g. muscle overuse, mechanical overloador psychological stress). Under normal conditions,pain from TrPs is mediated by thin myelinated (Ad)fibres and unmyelinated (C) fibres (57). Variousnoxious and innocuous events, such as mechanicalstimuli or chemical mediators, may excite and sen-sitize Adfibres and C fibres and thereby play a role

    in the development of TrPs (58). Recent studieshave hypothesized that the pathogenesis of TrPscould result from injured or overloaded musclefibres (59). This could lead to endogenous (invol-untary) shortening, loss of oxygen supply, loss ofnutrient supply and increased metabolic demandon local tissues (60). However, these events havenot been completely proven and more research isneeded.

    The most credible aetiological suggestion of TrPsis the integrated hypothesis, which hypothesizesthat abnormal depolarization of motor endplates

    and sustained muscular contraction give rise to alocalized ATP energy crisis associated with sen-sory and autonomic reflex arcs that are sustained bycentral sensitization (61). A recent study foundhigher levels of pain when a noxious stimulus wasapplied to the motor endplate region comparedwith silent muscle sites (62). In addition, painevoked from motor endplate regions was describedas throbbing, sharp or aching; similar descriptionsto TrP referred pain sensations (55). It has beensuggested that a higher density of muscle nocicep-tors in the vicinity of the motor endplate regionmay account for the observed differences in pain

    (62), but this has not been confirmed in otherstudies. Furthermore, endplate noise and endplatespikes [electromyographic (EMG) signal from dys-functional motor endplate regions] has been iden-tified and significantly associated with TrPs (63, 64).Findings from these studies support the theory thatTrPs could be dysfunctional motor endplates (65);however, further studies are required.

    Further, it has been previously assumed that con-traction of head, neck or shoulder muscles could

    386 C Fernndez-de-las-Peas et al.

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    5/11

    play a relevant role in the development of TTH.However, numerous surface EMG studies havereported normal or, more often, only slightlyincreased muscle activity in TTH (6672). A pioneerstudy analysing EMG activity with needle elec-trodes found an increased EMG activity in TrPscompared with an adjacent non-tender point (73).Furthermore, spontaneous EMG activity (endplatenoise) in the TrPs was significantly higher inpatients with CTTH than in healthy controls (73).Since the endplate region of a muscle fibre is only0.1 mm at the most in diameter, the increased EMGactivity (motor endplate noise and spikes) could bedetected only with needle electrodes preciselyplaced within the TrP. A histopathological cause oftaut bands in human trPs has not been convincinglydemonstrated. Many findings confirm the presenceof excessive muscle-fibre tension, but fail to identifyadequately what causes the tension. Also, there is

    scientific evidence showing that increased auto-nomic activity increases endplate noise and clinicalsymptoms caused by TrPs, but the specific mediatorof this link is conjectural; norepinephrin is a likelycandidate. Finally, although there is evidence tosupport the integrated hypothesis of an aetiologicalorigin of TrPs, the above-mentioned studies haveseveral shortcomings which should be addressed infuture studies in order to confirm definitively thisetiological hypothesis as the genesis of TrPs.

    Finally, it has been recently demonstrated thatactive TrPs may cause peripheral sensitization of

    muscle nociceptors, since higher levels of algogenicsubstances and lower pH levels have been found inactive TrPs compared with both latent TrP andtender points (40).

    Myofascial trigger points referred painin TTH

    In their comprehensive text, Simons et al. havedescribed the referred pain patterns from differentTrPs in several head and neck muscles which havethe potential to refer pain to the head: upper tra-pezius, temporalis, sternocleidomastoid, spleniis

    capitis, suboccipital muscles, etc. (Fig. 1) (55). SinceTTH is characterized by bilateral, pressing or tight-ening pain; pressure or band-like tightness; and/or increased tenderness on palpation of neck andshoulder muscles (74), these pain features resemblethe descriptions of referred pain originating in TrPs(55).

    Recent studies have demonstrated clinical evi-dence of the presence of TrPs in certain neck andshoulder muscles in CTTH. Marcus et al. found, in

    a non-blinded study, that TTH subjects had agreater number of either active or latent TrPs thanhealthy subjects (75). However, these authors didnot specify in which muscles TrPs were observedmore frequently. Similar findings have been re-ported for osteoarthritis patients (37). We recentlydemonstrated, in blinded controlled studies, thatCTTH is associated with active TrPs in the suboc-cipital muscles (76), and in the upper trapezius,sternocleidomastoid and temporalis muscles (77).All CTTH patients had active TrPs which, whenpressed, elicited referred pain that reproduced thesame head pain as during their headache attacks(Fig. 2). We also found that those CTTH patientswith active TrPs had greater headache intensity andfrequency than those with latent TrPs, which can beconsidered as temporal integration of the nocicep-tive barrage from TrPs (76, 77). In addition, inanother study we also found that patients with

    CTTH with bilateral TrPs in the upper trapeziusmuscle had greater headache pain, longer headacheduration and lowered pressure pain thresholdscompared with those with unilateral TrPs, whichcan be considered as spatial integration of nocice-ptive inputs from muscle TrPs (78). In these studiesactive TrPs, which referred a pain pattern thatreproduced the patients pain, were bilaterallylocated in CTTH (7578). In a recent study, wefound that patients with strictly unilateral migraineshowed a unilateral distribution of active TrPswhich were mostly located ipsilateral to migraine

    headaches compared with the non-symptomaticside (79). These findings support that, in patientswith bilateral TTH, referred pain from active TrPscould be contributing to their headache perception,since TrPs were located on both sides in most ofthem (7578).

    Although there is scientific evidence for a closerelationship between TrPs in certain head and neckmuscles and CTTH (7578), the type of researchdata reported to date does not establish a cause-and-effect relationship between TrPs and CTTH. Itis known that central sensitization may also beinvolved in the generation of muscle referred pain

    from TrPs (80). Different studies have found that thearea of the referred pain correlated with the inten-sity of the muscle pain in patients with sensitizationof central pathways (81). It has been suggested thatreferred pain in deep somatic secondary hyperal-gesia areas resembles that found in secondary hype-ralgesic areas at the skin following, for example,capsaicin application (82). In that way, musclereferred pain may also correlate with the phenom-ena of secondary hyperalgesia and tenderness seen

    Myofascial trigger points and sensitization 387

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    6/11

    in CTTH patients (81). In addition, peripheral andcentral sensitization, and decreased descendinginhibition induced by long-term nociceptive stimulifrom TrPs, may also be involved in referred pain(83). Larger referred pain areas have been foundin chronic musculoskeletal conditions, e.g. fibro-myalgia (84), whiplash (85) and myofascial tem-poromadibular pain patients (86). These studieshave demonstrated that patients with central

    sensitization showed larger referred pain areas inboth symptomatic areas and distant, not usuallysymptomatic areas (e.g. tibialis anterior muscle),which indicates that nociceptive inputs to thecentral nervous system may facilitate the referredpain mechanisms possibly resulting from centralsensitization (38). In addition, we have found largerreferred pain areas from upper trapezius muscleTrPs in CTTH patients compared with healthy

    Upper trapezius Sternocleidomastoid

    Semispinalis cervicis

    Temporalis muscle

    Splenius capitis muscle Splenius cervicis muscle

    Suboccipital musclesClavicular divisionSternal division

    Figure 1 Referred pain patterns from upper trapezius, sternocleidomastoid, suboccipital, splenius capitis, splenius cervicis,semispinalis capitis and temporalis muscle trigger points as described by Simons et al. Reprinted with permission fromSimons D, Travell J, Simons L. Travell & Simons myofascial pain and dysfunction: the trigger point manual, Vol. 1, 2ndedn. Baltimore: Williams & Wilkins, 1999.

    388 C Fernndez-de-las-Peas et al.

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    7/11

    subjects (78). These studies support the hypothesisthat the area of muscle referred pain provoked byTrPs in neck and shoulder muscles could beenlarged in CTTH patients, contributing to sensiti-zation of central pathways.

    Since active TrPs are related to several chronicconditions accounting for sensitization of centralpathways, the question arising should be: are activeTrPs the consequence of central sensitization? If thecentral sensitization were causing active TrPs, theywould not be expected in patients suffering from

    episodic TTH (ETTH), in which central sensitizationhas not been demonstrated (11). Since there is alesser degree of central senzitisation in ETTH,because of the intermittent nature of the condition,one would expect fewer active and more latent TrPsin ETTH than in CTTH. We have demonstrated thatactive TrPs in the suboccipital, upper trapezius,sternocleidomastoid and temporalis muscles arealso present in ETTH (87, 88), to a similar degree asin CTTH (76, 77). However, active TrPs were notrelated to headache clinical parameters in ETTH,supporting the hypothesis that there was no tem-poral summation of peripheral nociceptive inputs

    in patients with ETTH, due the intermittent natureof the condition. These findings indicate that activeTrPs are not the consequence of central sensitiza-tion, since they are also present in ETTH.

    Based on available data, we can make twoassumptions: (i) myogenic referred pain elicited byactive TrPs in head, neck and shoulder musclescontribute to headache pain patterns in TTHpatients (7578, 87, 88); and (ii) persistent periph-eral sensitization provoked by algogenic substances

    elicited by active TrPs (40), could lead to sensitiza-tion of nociceptive second-order neurons at thelevel of the spinal dorsal/trigeminal nucleus.

    Updated pain model for TTH

    Olesen (89) has suggested that perceived headacheintensity might be due to the sum of nociceptiveinputs from cranial and extracranial tissues con-verging on the neurons of the trigeminal nucleuscaudalis. Bendtsen (11) has suggested that the

    barrage of peripheral nociceptive inputs is respon-sible for the development of central sensitization.Our updated model suggests that TrPs located inhead and neck muscles innervated by C1C3 (e.g.upper trapezius, sternocleidomastoid, suboccipitalmuscles) or by the trigeminal nerve (e.g. temporalis,masseter) are responsible for the peripheral nocice-ptive input and could produce a continuous affer-ent barrage into the trigeminal nerve nucleuscaudalis. Connections between afferents innervat-ing deep structures and second-order neuronscould be altered by these nociceptive afferent inputsfrom muscle TrPs. Convergent synaptic connections

    on dorsal horn neurons, which are not usuallyfunctional, could be activated if intense nociceptiveinput reaches the dorsal horn. Changes in size andshape of peripheral receptive fields, and the forma-tion of new receptive fields, would occur if nocice-ptive barrage from muscle TrPs is maintainedduring time. This would result in temporal andspatial integration of neuron signals and might beone of the reasons for the central sensitization inCTTH.

    Referred pain patterns from muscle TrPs TTH(a) (b)

    Upper trapezius muscle

    Sternocleidomastoid muscle

    Suboccipital muscles

    Head pain pattern inTTH

    Figure 2 Similarities between the elicited referred pain from manual examination of upper trapezius, sternocleidomastoidand suboccipital muscle trigger point (TrP) in tension-type headache (TTH) patients (a) and the head pain patterndescribed by patients themselves (b).

    Myofascial trigger points and sensitization 389

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    8/11

    Based on new available data, an updated painmodel for TTH could be hypothesized as follows:TTH can at least partly be explained by referredpain from TrPs in the posterior cervical, head(including extraocular muscles) and shouldermuscles, mediated through the spinal cord and thebrainstem trigeminal nucleus caudalis, rather thanonly tenderness of the pericranial muscles them-

    selves. In this updated pain model, we could con-sider TrPs as primary hyperalgesic zones in whichreferred pain areas to the head exhibit increasedtenderness and decreased pressure pain thresholds(secondary hyperalgesic zones). Figure 3 illustratesthe updated pain model for TTH.

    Finally, a TrP role in headache does not negatethe importance of other physical (e.g. malalignmentof upper cervical vertebrae (90) or forward headposture (91)) or psychological (e.g. anxiety ordepression) factors in exacerbating and sustainingCTTH. It is of great clinical interest to note thatthese same factors are known to aggravate and

    promote TrP activity. Many elements traditionallydeemed important in the genesis of CTTH mayresult from inadequate strategies devised to copewith TrP-induced head pain.

    In conclusion, an updated pain model for CTTHhas been proposed in which headache can be atleast partly caused by referred pain from activeTrPs in the posterior cervical, head and shouldermuscles mediated through the spinal cord and thebrainstem trigeminal nucleus caudalis. In this

    updated pain model, TrPs would be the primaryhyperalgesic zones responsible for the developmentof central sensitization in CTTH. If this model isvalid, every patient seen for TTH needs to beexamined for TrPs, which are often apparently con-tributing significantly to their symptoms.

    References

    1 Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemi-ology of tension-type headache. JAMA 1998; 279:3813.

    2 Bendtsen L, Jensen R. Tension type headache: the mostcommon, but also the most neglected headache disorder.Curr Opin Neurol 2006; 19:3059.

    3 Jensen R, Olesen J. Initiating mechanism of experimen-tally induced tension-type headache. Cephalalgia 1996;16:17582.

    4 Lipchik GL, Holroyd KA, Talbot F, Greer M. Pericranialmuscle tenderness and exteroceptive suppression of tem-poralis muscle activity: a blind study of chronic tension-type headache. Headache 1997; 37:36876.

    5 Metsahonkala L, Anttila P, Laimi K, Aromaa M, HeleniusH, Mikkelsson M et al. Extra-cephalic tenderness andpressure pain threshold in children with headache. Eur JPain 2006; 10:5815.

    6 Langemark M, Olesen J. Pericranial tenderness in tensionheadache. A blind controlled study. Cephalalgia 1987;7:24955.

    7 Jensen R, Rasmussen BK, Pederken B, Olesen J. Muscletenderness and pressure pain threshold in headache: apopulation study. Pain 1993; 52:1939.

    8 Schoenen J, Bottin D, Hardy F, Gerard P. Cephalic andextra-cephalic pressure pain thresholds in chronic tensiontype headache. Pain 1991; 47:1459.

    Peripheral sensitization

    Sensitization of centralpathways

    Myofascial TrPs (referred pain pattern)

    Liberation of algogenicmediators

    Updated pain model for TTH

    Aand C fibres

    Nociceptive barrage

    Increased paintransmission

    Afibres

    Sensitization of second-orden neurons in the dorsal horn(trigeminal nucleus caudalis)

    Sesory cortex and thalamus(Inhibition of periaqueductal grey substance)

    Figure 3 Updated pain model for tension-type headache (TTH) in which peripheral sensitization provoked by muscletrigger points (TrPs) can lead to sensitization of dorsal-horn neurons.

    390 C Fernndez-de-las-Peas et al.

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    9/11

    9 Bendtsen L, Jensen R, Olesen J. Decreased pain detectionand tolerance thresholds in chronic tension type head-ache. Arch Neurol 1996; 53:3736.

    10 Ashina S, Babenko L, Jensen R, Ashina M, Magerl W,Bendtsen L. Increased muscular and cutaneous painsensitivity in cephalic region in patients with chronictension-type headache. Eur J Neurol 2005; 12:5439.

    11 Bendtsen L. Central sensitization in tension-type head-ache: possible patho-physiological mechanisms. Cephala-lgia 2000; 29:486508.

    12 Mense S. Nociception from skeletal muscle in relation toclinical muscle pain. Pain 1993; 54:24189.

    13 Yu XM, Mense S. Response properties and descendingcontrol of rat dorsal horn neurons with deep receptivefields. Neuroscience 1990; 39:82331.

    14 Woolf CJ. Evidence for a central component of postinjurypain hypersensitivity. Nature 1983; 15:6868.

    15 McMahon SB, Lewin GR, Wall PD. Central hyperexcit-ability triggered by noxious inputs. Curr Opin Neurobiol1993; 3:60210.

    16 Hoheisel U, Sander B, Mense S. Myositis-induced func-tional reorganisation of the rat dorsal horn: effects of

    spinal superfusion with antagonists to neurokinin andglutamate receptors. Pain 1997; 69:21930.

    17 Babenko V, Graven-Nielsen T, Svenson P, Drewes MA,Jensen TS, Arendt-Nielsen L. Experimental humanmuscle pain and muscular hyperalgesia induced bycombinations of serotonin and bradykinin. Pain 1999;82:18.

    18 Mork H, Ashina M, Bendtsen L, Olesen J, Jensen R.Experimental muscle pain and tenderness following infu-sion of endogenous substances in humans. Eur J Pain2003; 7:14553.

    19 OBrien C, Woolf CJ, Fitzgerald M, Lindsay RM, Molan-der C. Differences in the chemical expression of ratprimary afferent neurons which innervate skin, muscle or

    joint. Neuroscience 1989; 32:493502.20 Mense S, Simons DG, Russell IJ. Muscle pain: under-

    standing its nature, diagnosis and treatment. Philadel-phia: Lippincott Williams & Wilkins 2001.

    21 Mork H, Ashina M, Bendtsen L, Olesen J, Jensen R.Induction of prolonged tenderness in patients withtension-type headache by means of a new experimentalmodel of myofascial pain. Eur J Neurol 2003; 10:24956.

    22 Christensen MB, Bendtsen L, Ashina M, Jensen R. Experi-mental induction of muscle tenderness and headache intension-type headache patients. Cephalalgia 2005; 25:10617.

    23 Schmidt RF. Sensitization of peripheral nociceptors inmuscle. In: Olesen J, Schoenen J, editors. Tension-type

    headache: classification, mechanisms, and treatment.New York: Raven Press 1993:4759.

    24 Bendtsen L, Jensen R, Olesen J. Qualitative altered noci-ception in chronic myofascial pain. Pain 1996; 65:25964.

    25 Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R. Fre-quency of headache is related to sensitization: a popula-tion study. Pain 2006; 123:1927.

    26 Mendell LM, Wall PD. Responses of single dorsal cordcells to peripheral cutaneous unmyelinated fibres. Nature1965; 206:979.

    27 Wall PD, Woolf CJ. Muscle but not cutaneous C-afferent

    input produces prolonged increases in the excitability ofthe flexion reflex in the rat. J Physiol 1984; 356:44358.

    28 Woolf CJ, Thompson SW. The induction and maintenanceof central sensitization is dependent on N-methyl-Daspartic acid receptor activation; implications for thetreatment of postinjury pain hypersensitivity states. Pain1991; 44:2939.

    29 Hoheisel U, Mense S, Simons DG, Yu XM. Appearance ofnew receptive fields in rat dorsal horn neurons followingnoxious stimulation of skeletal muscle: a model for refer-ral of muscle pain? Neurosci Lett 1993; 153:912.

    30 Woolf CJ, Doubell TP. The pathophysiology of chronicpain increased sensitivity to low threshold A beta-fibreinputs. Curr Opin Neurobiol 1994; 4:52534.

    31 Ashina S, Jensen R, Bendtsen L. Pain sensitivity in peri-cranial and extra-cranial regions. Cephalalgia 2003;23:45662.

    32 Sterling M, Jull G, Vicenzino B, Kenardy J. Sensory hyper-sensitivity occurs soon after whiplash injury and associ-ated with poor recovery. Pain 2003; 104:50917.

    33 Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribu-tion of central neuroplasticity to pathological pain: review

    of clinical and experimental evidence. Pain 1993; 52:25985.

    34 Lamour Y, Guilbaud G, Willer JC. Altered properties andlaminar distribution of neuronal responses to peripheralstimulation in the SmI cortex of the arthritic rat. Brain Res1983; 22:1837.

    35 Wall PD, Devor M. The effect of peripheral nerve injuryon dorsal root potentials and on transmission of afferentsignals into the spinal cord. Brain Res 1981; 23:95111.

    36 Ashina S, Bendtsen L, Ashina M, Magerl W, Jensen R.Generalized hyperalgesia in patients with chronictension-type headache. Cephalalgia 2006; 26:9408.

    37 Bajaj P, Graven-Nielsen T, Arendt-Nielsen L. Osteoarthri-tis and its association with muscle hyperalgesia: an

    experimental controlled study. Pain 2001; 93:10714.38 Arendt-Nielsen L, Graven-Nielsen T. Central sensitisation

    in fibromyalgia and other musculoskeletal disorders.Curr Pain Headache Rep 2003; 7:35561.

    39 Ashina M, Stallknecht B, Bendtsen L, Pedersen JF,Schifter S, Galbo H, Olesen J. Tender points are not sitesof ongoing inflammationin vivo evidence in patientswith chronic tension-type headache. Cephalalgia 2003;23:10916.

    40 Shah JP, Phillips TM, Danoff JV, Gerber LH. An in vitromicroanalytical technique for measuring the local bio-chemical milieu of human skeletal muscle. J Appl Physiol2005; 99:197784.

    41 Hoheisel U, Koch K, Mense S. Functional reorganization

    in the rat dorsal horn during an experimental myositis.Pain 1994; 59:1118.

    42 Nyberg G, Blomqvist A. The central projection of muscleafferent fibers to the lower medulla and upper spinalcord: an anatomical study in the cat with the transgang-honic transport method. J Comp Neurol 1984; 230:99108.

    43 Abrahams VC, Swett JE. The pattern of spinal and med-ullary projections from a cutaneous nerve and a musclenerve of the forelimb of the cat: a study using transgang-honic transport of HRP. J Comp Neurol 1986; 246:7084.

    44 Bartsch T, Goadsby PJ. Stimulation of the greater occipital

    Myofascial trigger points and sensitization 391

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    10/11

    nerve induces increased central excitability of dural affer-ent input. Brain 2002; 125:1496509.

    45 Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence ofcervical and trigeminal sensory afferents. Curr PainHeadache Report 2003; 7:37783.

    46 Ge HY, Wang K, Madeleine P, Svensson P, Sessle BJ,Arendt-Nielsen L. Simultaneous modulation of theexteroceptive suppression periods in the trapezius andtemporalis muscles by experimental muscle pain. ClinNeurophysiol 2004; 115:1399408.

    47 Schaible HG, Schmidt RF, Willis WD. Convergent inputsfrom articular, cutaneous and muscle receptors ontoascending tract cells in the cat spinal cord. Exp Brain Res1987; 66:47988.

    48 Hoheisel U, Mense S. Response behaviour of cat dorsalhorn neurones receiving input from skeletal muscle andother deep somatic tissues. J Physiol (Lond) 1990; 426:26580.

    49 Mense S. Referral of muscle pain: new aspects. Am PainSoc J 1994; 3:19.

    50 Simons DG. Neuro-physiological basis of pain caused bytrigger points. Am Pain Soc J 1994; 3:179.

    51 Graven-Nielsen T, Arendt-Nielsen L, Svensson P, JensenTS. Experimental muscle pain: a quantitative study oflocal and referred pain in humans following injection ofhypertonic saline. J Musculoskel Pain 1997; 5:4969.

    52 Schmidt-Hansen PT, Svensson P, Jensen TS, Graven-Nielsen T, Bach FW. Patterns of experimentally inducedpain in peri-cranial muscles. Cephalalgia 2006; 26:56877.

    53 Ge HY, Madeleine P, Wang K, Arendt-Nielsen L. Hypoal-gesia to pressure pain in referred pain areas triggered byspatial summation of experimental muscle pain fromunilateral or bilateral trapezius muscles. Eur J Pain 2003;7:5317.

    54 Ge HY, Arendt-Nielsen L, Farina D, Madeleine P.Gender-specific differences in electromyographic changes

    and perceived pain induced by experimental muscle painduring sustained contractions of the upper trapeziusmuscle. Muscle Nerve 2005; 32:72633.

    55 Simons DG, Travell J, Simons LS. Travell and Simonsmyofascial pain and dysfunction: the trigger pointmanual, Vol. 1, 2nd edn. Baltimore: Williams & Wilkins1999.

    56 Lucas KR, Polus BI, Rich PA. Latent myofascial triggerpoints: their effects on muscle activation and movementefficiency. J Bodywork Mov Ther 2004; 8:1606.

    57 Newham DJ, Edwards RHT, Mills KR. Skeletal musclepain. In: Wall PD, Melzack R, editors. Textbook of pain,3rd edn. Edinburgh: Churchill Livingstone 1994:42340.

    58 Mense S. Peripheral mechanisms of muscle nociception

    and local muscle pain. J Musculoskeletal Pain 1993;1:13370.

    59 Gerwin RD, Dommerholt D, Shah JP. An expansion ofSimons integrated hypothesis of trigger point formation.Curr Pain Head Rep 2004; 8:46875.

    60 Simons DG. Review of enigmatic MTrPs as a commoncause of enigmatic musculoskeletal pain and dysfunction.

    J Electromyogr Kinesiol 2004; 14:95107.61 McPartland JM, Simons DG. Myofascial trigger points:

    translating molecular theory into manual therapy. J ManManipul Therapy 2006; 14:2329.

    62 Qerama E, Fuglsang-Frederiksen A, Kasch H, Bach FW,Jensen TS. Evoked pain in motor endplate region of thebrachial biceps muscle: an experimental study. MuscleNerve 2004; 29:393400.

    63 Simons DG. Do endplate noise and spikes arise fromnormal motor endplates? Am J Pphys Med Rehabil 2001;80:13440.

    64 Coupp C, Midttun A, Hilden J, Jorgensen U, Oxholm P,Fuglsang-Frederiksen A. Spontaneous needle electromyo-graphic activity in myofascial trigger points in theinfraspinaturs muscle: a blinded assessment. J MusculoskPain 2001; 9:716.

    65 Simons DG, Hong CZ, Simons LS. Endplate potentials arecommon to midfiber myofascial trigger points. Am J PhysMed Rehabil 2002; 81:21222.

    66 Schoenen J, Gerard P, De Pasqua V, Sianard Gainko J.Multiple clinical and paraclinical analyses of chronictension type headache associated or un-associated withdisorder of pericranial muscles. Cephalalgia 1991;11:1359.

    67 Hatch JP, Prihoda TJ, Moore PJ, Cyr-Provost M, Borcherd-ing S, Boutros NN et al. A naturalistic study of the

    relationships among electromyographic activity, psycho-logical stress, and pain in ambulatory tension-type head-ache patients and headache-free controls. PsychosomMed 1991; 53:57684.

    68 Goebel H, Weigle L, Kropp P, Soyka D. Pain sensitivityand pain reactivity of pericranial muscles in migraine andtension-type headache. Cephalalgia 1992; 12:14251.

    69 Jensen R, Fuglsang-Frederiksen A, Olesen J. Quantitativesurface EMG of pericranial muscles in headache. A popu-lation study. Electroencephalogr Clin Neurophysiol 1994;93:35544.

    70 Sandrini G, Antonaci F, Pucci E, Bono G, Nappi G.Comparative study with EMG, pressure algometry andmanual palpation in tension-type headache and migraine.

    Cephalalgia 1994; 14:4517.71 Clark GT, Sakai S, Merrill R, Flack VF, McCreary C.

    Cross-correlation between stress, pain, physical activity,and temporalis muscle EMG in tension-type headache.Cephalalgia 1995; 15:5118.

    72 Jensen R. Mechanisms of spontaneous tension-type head-aches: an analysis of tenderness, pain thresholds andEMG. Pain 1996; 64:2516.

    73 Hubbard DR, Berkoff GM. Myofascial trigger pointsshow spontaneous needle EMG activity. Spine 1993;18:18037.

    74 Headache Classification Subcommittee of the Interna-tional Headache Society. The International Classificationof Headache Disorders, 2nd edition. Cephalalgia 2004;24

    (Suppl. 1):9160.75 Marcus DA, Scharff L, Mercer S, Turk DC. Musculoskel-

    etal abnormalities in chronic headache: a controlled com-parison of headache diagnostic groups. Headache 1999;39:217.

    76 Fernndez-de-las-Peas C, Alonso-Blanco C, CuadradoML, Gerwin RD, Pareja JA. Trigger points in the suboc-cipital muscles and forward head posture in tension typeheadache. Headache 2006; 46:45460.

    77 Fernndez-de-las-Peas C, Alonso-Blanco C, CuadradoML, Gerwin RD, Pareja JA. Myofascial trigger points and

    392 C Fernndez-de-las-Peas et al.

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393

  • 7/24/2019 27. Cephalalgia2007Updated Pain Model

    11/11

    their relationship with headache clinical parameters inchronic tension type headache. Headache 2006; 46:126472.

    78 Fernndez-de-las-Peas C, Ge HY, Arendt-Nielsen L,Cuadrado ML, Pareja JA. Referred pain from trapeziusmuscle trigger point shares similar characteristics withchronic tension type headache. Eur J Pain 2006; doi.:10.1016/j.ejpain.2006.07.005.

    79 Fernndez-de-las-Peas C, Cuadrado ML, Pareja JA.Myofascial trigger points, neck mobility and forwardhead posture in unilateral migraine. Cephalalgia 2006;26:106170.

    80 Arendt-Nielsen L, Svensson P. Referred muscle pain:basic and clinical findings. Clin J Pain 2001; 17:119.

    81 Graven-Nielsen T, Arendt-Nielsen L, Svensson P, JensenT. Quantification of local and referred muscle pain inhumans after sequential intramuscular injections ofhypertonic saline. Pain 1997; 69:1117.

    82 Gazerani P, Andersen OK, Arendt-Nielsen L. A humanexperimental capsaicin model for trigeminal sensitization.Gender-specific differences. Pain 2005; 118:15563.

    83 Arendt-Nielsen L, Laursen RJ, Drewes A. Referred pain

    as an indicator for neural plasticity. Prog Brain Res 2000;129:34356.

    84 Srensen J, Graven-Nielsen T, Henriksson KG, BengtssonM, Arendt-Nielsen L. Hyperexcitability in fibromyalgia.

    J Rheumatol 1998; 25:1525.

    85 Johansen MK, Graven-Nielsen T, Olesen AS, Arendt-Nielsen L. Generalized muscular hyperalgesia in chronicwhiplash syndrome. Pain 1999; 83:22934.

    86 Svensson P, List T, Hector G. Analysis of stimulus-evoked pain in patients with myofascial temporoman-dibular pain disorders. Pain 2001; 92:399409.

    87 Fernndez-de-las-Peas C, Alonso-Blanco C, CuadradoML, Pareja JA. Myofascial trigger points in the suboccipi-tal muscles in episodic tension type headache. Man Ther2006; 11:22530.

    88 Fernndez-de-las-Peas C, Cuadrado ML, Pareja JA.Myofascial trigger points, neck mobility and forwardhead posture in episodic tension type headache.Headache 2006; doi.: 10.1111/j.1526-4610.2006.00632.x.

    89 Olesen J. Clinical and pathophysiological observations inmigraine and tension-type headache explained by inte-gration of vascular, supraspinal and myofascial inputs.Pain 1991; 46:12532.

    90 Bogduk N. Cervicogenic headache: anatomic basis andpathophysiologic mechanisms. Curr Pain HeadacheReport 2001; 5:2826.

    91 Fernndez-de-las-Peas C, Alonso-Blanco C, Cuadrado

    ML, Pareja JA. Forward head posture and neck mobilityin chronic tension type headache: a blinded, controlledstudy. Cephalalgia 2006; 26:3149.

    Myofascial trigger points and sensitization 393

    Blackwell Publishing Ltd Cephalalgia, 2007, 27, 383393